Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations

Stock Quote

NASDAQCRDF
$1.71
NASDAQCRDF
Open
$1.70
Change
$0.04 (2.40%)
Day's Range
$1.66 - $1.77
52-Week Range
$0.94 - $2.79
Volume
132.4K
Market Cap
$76.4M